Compounds > thioridazine
Page last updated: 2024-11-05

thioridazine and Cancer of Ovary

thioridazine has been researched along with Cancer of Ovary in 2 studies

Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, MS1
Dong, SM1
Kim, BR2
Seo, SH1
Kang, S2
Lee, EJ1
Lee, SH1
Rho, SB2

Other Studies

2 other studies available for thioridazine and Cancer of Ovary

ArticleYear
Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts.
    Oncotarget, 2014, Jul-15, Volume: 5, Issue:13

    Topics: Animals; Antipsychotic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Proteins; Cell L

2014
A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)/AKT pathway in ovarian cancer cells.
    Gynecologic oncology, 2011, Volume: 120, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Growth Processes; Cell Line, Tumor;

2011